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A B S T R A C T
Soluble defense collagens form a group of secreted proteins that are primarily involved in host defense. All
defense collagens contain a globular recognition domain contiguous to a collagen-like triple helical domain.
They are oligomeric proteins, assembled in multiples of three subunits due to their collagen domains. Members
of this group include collectins such as surfactant protein A and D (SP-A, SP-D), and mannan-binding lectin; C1q,
the ﬁrst component of the complement system; adiponectin; and ﬁcolins. All are secreted to tissue cavities or
serum. Soluble defense collagens are specialized to respond to infection, triggering the initiation of the com-
plement cascade and/or enhancing phagocytosis of pathogens by macrophages. However, once inﬂammation is
established, C1q, collectins, ﬁcolins, or adiponectin can inﬂuence macrophage responses, thereby contributing to
resolve the inﬂammation. In addition, some members of this group of proteins (SP-A, C1q, and adiponectin)
modulate tissue-repair functions of macrophages. This review will focus on the molecular mechanisms by which
these proteins eﬃciently defend against immune threats and contribute to tissue repair.
1. Introduction
The term ‘defense collagens’ distinguishes a growing family of
proteins, involved in host defense, from structural collagens that con-
stitute the extracellular matrix. They are highly conserved across
mammalian species and include i) integral membrane proteins such as
class A scavenger receptors (SR-A1, SR-A3-5, and MARCO) (Zani et al.,
2015; PrabhuDas et al., 2017) and ii) proteins secreted to tissue cavities
and/or serum (Tenner, 1999; Fraser and Tenner, 2008). In this review,
we will focus on human secreted defense collagens, which display a
wide range of binding properties to immune targets and cell surface
receptors through their globular head regions and collagen-like do-
mains. These soluble pattern recognition molecules serve to identify
pathogen-associated molecular patterns (PAMPs) (Medzhitov and
Janeway, 2002) and danger-associated molecular patterns (DAMPs)
(Matzinger, 1994; Venereau et al., 2015).
The human soluble defense collagens considered in this review are
enumerated in Table 1. They include three sets of defense collagens: (a)
members of the collectin family (CL): surfactant protein A and D (SP-A
and SP-D), mannan-binding lectin (MBL), collectin liver-1 (CL-L1 aka
CL-10), collectin kidney-1 (CL-K1 aka CL-11), and the heterotrimeric
CL-LK formed by the combination of CL-K1 and CL-L1 polypeptides
(Casals et al., 2018); (b) two members of the C1q and TNF-related
proteins (CTRP) family: C1q, the ﬁrst subcomponent of the complement
classical activation pathway, and adiponectin (Kishore et al., 2004;
Ressl et al., 2015); and (c) members of the ﬁcolin family: M-ﬁcolin
(ﬁcolin 1), L-ﬁcolin (ﬁcolin 2) and H-ﬁcolin (ﬁcolin 3) (Matsushita,
2010).
SP-A and SP-D are secreted to the airway mucosa by alveolar epi-
thelial type II cells and nonciliated bronchiolar cells. They are also
detected in the trachea and nasal mucosa, where they provide immune
protection (Casals et al., 2018). SP-A and SP-D are also present in other
extra-pulmonary mucosal surfaces and tissues, such as the middle ear,
the ocular system (cornea, conjunctiva, and tear ﬂuid), the digestive,
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urinary and reproductive tracts, the skin, the brain, and the synovial
ﬂuid (Ujma et al., 2017). However, SP-A and SP-D are not secreted to
the serum. MBL is secreted by hepatocytes to the serum (Heitzeneder
et al., 2012), and CL-L1 and CL-K1 are present in the serum and several
tissues, with high expression in secretory and mucosal epithelia, similar
to SP-D (Hansen et al., 2018). In circulation, the majority of CL-K1
forms part of the heteromeric protein CL-LK (Hansen et al., 2016). C1q
is expressed and secreted mainly by myeloid cells, including monocytes,
macrophages, dendritic cells, and microglial cells, and also by epithe-
lial, endothelial, and mesenchymal cells, ﬁbroblasts, and trophoblasts
(Thielens et al., 2017; Reid, 2018). C1q is secreted to the local en-
vironment and the serum, where it has the highest concentration of the
defense collagens found in serum. Adiponectin, with multiple functions
in whole body metabolism, is speciﬁcally expressed in adipose tissue
and is secreted to the serum (Wang and Scherer, 2016). Adiponectin
plasma levels show sexual dimorphism since women have signiﬁcantly
higher adiponectin levels than men (Atzmon et al., 2008). Ficolins are
secreted to the serum and to tissue cavities showing tissue-dependent
distribution. mRNA of L-ﬁcolin is mainly expressed in the liver and is
secreted to serum. H-ﬁcolin mRNA is expressed in the liver and lung. In
the liver, H-ﬁcolin is secreted by epithelial bile duct cells to the bile and
by hepatocytes to the serum. In the lung, H-ﬁcolin is secreted to the
airways by bronchial epithelial cells and type II alveolar epithelial cells.
M-ﬁcolin is secreted by neutrophils, monocytes/macrophages, and al-
veolar type II cells, and it is found in plasma at very low concentrations
(Matsushita, 2010). With respect to chromosomal location, this family
of proteins maps to diﬀerent chromosomal locations. MBL, SP-A1, SP-A-
2, and SP-D map to the long arm of chromosome 10; the genes for CL-L1
and CL-K1 are on chromosomes 8 and 2, respectively; the genes for M-
and L-ﬁcolin are located on chromosome 9, whereas H-ﬁcolin is on
chromosome 1; the three genes for C1qa, C1qb, and C1qc polypeptides
are on chromosome 1, while adiponectin is located on chromosome 3.
Most soluble defense collagens are specialized to respond to infec-
tion. C1q triggers the initiation of the complement cascade by the
classical pathway and MBL, CL-K1, CL-LK, and ﬁcolins do so by the
lectin pathway (Walport, 2001a, b; Fujita, 2002; Garred et al., 2016).
Complement activation promotes the phagocytosis of pathogens or
their direct lysis via the membranolytic attack complex (MAC) forma-
tion (Fig. 1). The activation of the complement cascade releases opsonic
C3b and iC3b fragments that mediate noninﬂammatory uptake of pa-
thogens by phagocytic cells, but also releases anaphylatoxins C3a and
C5a that are potent mediators of inﬂammation, recruiting leukocytes to
the site of infection. Some regulatory molecules prevent generation of
C3a, C5a, and MAC (Zipfel and Skerka, 2009). C1q, MBL, CL-LK, and
Table 1
Expression and secretion of human soluble defense collagens.
Protein name mRNA expression Protein detection Levels in serum References
SP-D Alveolar epithelial type II cells, bronchiolar Club
cells, trachea, and other mucosal epithelia
Lung, alveolar ﬂuid, and other mucosal
epithelia
0 Wright (2005), Ordonez
et al. (2017),
Ujma et al. (2017)
CL-L1
(CL-10)
Hepatocytes, epithelial cells of diﬀerent tissues Serum, liver, kidney, lung, digestive tract,
adrenal glands, and other secretory and
mucosal epithelia
˜ 0.5 μg/ml Troldborg et al. (2017),
Hansen et al. (2018)
CL-K1
(CL-11)
Hepatocytes, epithelial cells of diﬀerent tissues Serum, liver, kidney, lung, digestive tract,
adrenal glands, and other secretory and
mucosal epithelia
˜ 0.5 μg/ml Yoshizaki et al. (2012),
Troldborg et al. (2017),
Hansen et al. (2018)
SP-A Alveolar epithelial type II cells, bronchiolar Club
cells, trachea, and other mucosal epithelia
Lung, alveolar ﬂuid, and other mucosal
epithelia
0 Wright (2005), Ordonez
et al. (2017),
Ujma et al. (2017)
MBL Hepatocytes Serum 0.05-8 μg/ml (dependent
on MBL2 genotype)
Garred et al. (2003)
Heitzeneder et al. (2012)
C1q Myeloid cells Serum, tissue cavities 80 μg/ml Thielens et al. (2017), Reid
(2018)
Adiponectin Adipocytes Serum, adipose tissue ˜ 10-15 μg/ml Atzmon et al. (2008)
Wang and Scherer (2016)
Zhang et al. (2017)
L-ﬁcolin
(ﬁcolin 2)
Liver Serum, liver 5 μg/ml Matsushita (2010),
Garred et al. (2016)
M-ﬁcolin (ﬁcolin
1)
Peripheral
blood leukocytes, bone-marrow-derived cells,
spleen, and lung
Serum, alveolar ﬂuid, neutrophils,
monocytes, macrophages
0.3 μg/ml
H-ﬁcolin (ﬁcolin
3)
Liver (bile duct epithelial cells and hepatocytes);
lung (ciliated bronchial and alveolar epithelial
type II cells)
Serum, liver, bronchi, and alveolar ﬂuid 25 μg/ml
Fig. 1. Mechanisms used by soluble defense collagens to
respond to infection. C1q triggers the initiation of the com-
plement cascade by the classical pathway. MBL, CL-K1, CL-LK,
and ﬁcolins do so by the lectin pathway, leading to pathogen
opsonization by C3b, and to phagocytosis and/or lysis by
membrane attack complex formation. C1q, MBL, CL-LK, and
ﬁcolins also directly opsonize pathogens for phagocytic
clearance. SP-A and SP-D do not activate complement, but
they enhance pathogen aggregation and mucociliary clear-
ance, bacterial killing, and phagocytosis. The inﬂammation
triggered by these processes is depicted in light or dark
shading according to the color bar.
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ﬁcolins also have non-complement activation-related functions. They
recognize pathogens and lead to their clearance by phagocyte activa-
tion (Fig. 1). On the other hand, SP-A and SP-D do not activate the
complement cascade, which could be detrimental to the delicate al-
veolar epithelium and other vulnerable body interfaces (Watford et al.,
2000). However, they constantly survey the extracellular environment
for pathogens and quickly activate several mechanisms involved in
pathogen clearance without inducing strong inﬂammatory responses.
They bind to some microorganisms, which results in either bacterial
aggregation and mucociliary clearance and/or bacterial killing in sy-
nergy with antimicrobial factors; They also enhance phagocytosis of
pathogens by tissue macrophages (Wright, 2005; Coya et al., 2015;
Ordonez et al., 2017; Casals et al., 2018) (Fig. 1). With respect to adi-
ponectin, there are no reports to date indicating that this protein par-
ticipates in the clearance of pathogens.
Once infection is being eﬃciently fought, inﬂammation must be
resolved to avoid collateral tissue damage. Soluble defense collagens,
including adiponectin, contribute to resolution of inﬂammation by
limiting macrophage pro-inﬂammatory activation, promoting clearance
of dead cells (Bohlson et al., 2014), and enhancing tissue-repair func-
tions. This review will focus on common structural elements of soluble
defense collagens and on the molecular mechanisms by which these
proteins inﬂuence macrophage activation and may contribute to tissue
repair and tissue homeostasis.
2. Common structural elements of soluble defense collagens
Fig. 2 highlights the domain organization and high-order oligomers
of human soluble defense collagens. They are assembled in three or
multiples of three subunits, which are made up of three identical
polypeptides, except in the case of C1q, human SP-A, and CL-LK. C1q
trimers are assembled from three quite similar polypeptide chains (A, B,
and C) (Thielens et al., 2017). In human SP-A, unlike other mammalian
SP-A except that of baboons, there are two functional genes, resulting in
some diﬀerences in the corresponding proteins (SP-A1 and SP-A2)
(Floros and Hoover, 1998; Garcia-Verdugo et al., 2002). CL-LK trimers
are composed of two CL-K1 and one CL-L1 polypeptide chains (Hansen
et al., 2016).
The primary structure of each polypeptide chain consists of an N-
terminal segment containing cysteine residues involved in oligomer-
ization, followed by a collagen-like region, and a globular domain that
in collectins and ﬁcolins contains a carbohydrate recognition domain
(CRD). The CRD of collectins uses calcium ions to coordinate with the
hydroxyl groups of their carbohydrate ligands (Drickamer, 1999).
However, the CRD of ﬁcolins is a ﬁbrinogen-like globular (FBG) domain
that binds calcium, but the ion does not participate directly in sac-
charide binding (Garlatti et al., 2007). The globular recognition do-
mains of C1q and adiponectin do not contain a CRD. They assemble in a
similar way, exhibiting a compact, almost spherical trimeric assem-
blage, held together mainly by non-polar interactions, with a Ca2+ ion
bound at the top (Shapiro and Scherer, 1998; Gaboriaud et al., 2003).
A structural domain, which is present in collectins but not in ﬁcolin
and CTRP families, is the structure of the neck domain between the
collagen-like domain and the globular domains. The X-ray crystal-
lographic data for MBL (Weis and Drickamer, 1994), SP-D (Hakansson
et al., 1999), SP-A (Head et al., 2003), and CL-K1 (Venkatraman Girija
et al., 2015) demonstrated the existence of an α-helical coiled-coil
structure in the neck region. The amino acid sequence of this region is
characterized by a heptad repeat pattern a-b-c-d-e-f-g-d, where residues
“a” and “d” are hydrophobic amino acids. These hydrophobic amino
acids at every turn of the helix form the interior of the coiled-coil and
stabilize this structure. The α-helical coiled-coil structure is one of the
collectin domains essential for trimerization, together with the col-
lagen-like region and the interchain disulﬁde cross-linkage at the N-
terminal region. Researchers believe that the formation of trimers in
collectins occurs in a zipper-like fashion along the C-terminal to N-
terminal axis (Hakansson and Reid, 2000). Trimerization of C-terminal
globular domains, likely by the trimeric α-helical coiled-coil, takes
place before the triple-helix folding that aligns the polypeptide chains
for disulﬁde bond formation at the N-terminal segment. In the case of
ﬁcolins, C1q, and adiponectin, the domains essential for trimerization
are those outside the globular heads (the collagen-like domain and the
N-terminal segment, which contains cysteine residues) (Endo et al.,
2007; Garlatti et al., 2010b; Thielens et al., 2017; Reid, 2018).
Except for the globular domain, the domain organization of human
soluble defense collagens is drawn to scale in Fig. 2. The collagenous
region of these proteins varies considerably in length or number of Gly-
X-Y triplets (where X is often a proline, and Y is frequently a hydro-
xylysine or a hydroxyproline). SP-D contains 59 triplets, C1q 25, SP-A
23, adiponectin 22, CL-L1 20, MBL 18, CL-K1 16, and L-, M-, and H-
ﬁcolins 16, 15, and 11 triplets, respectively. The collagen sequence in
MBL, SP-A, and C1q is interrupted once, giving rise to a kink in the
collagen structure (Voss et al., 1988; Casals and García-Verdugo, 2005;
Jensenius et al., 2009; Thielens et al., 2017). For SP-A and C1q, in
which their collagen-like domain contains a sequence irregularity
(kink) near the middle of the collagen structure, lateral association of
Fig. 2. Domain organization and overall structures of
human soluble defense collagens. The domain organization
of polypeptide chains is drawn to scale, except for the globular
domain. The number of amino acids covering each domain is
shown. Interruptions in the collagen domain of SP-A, MBL,
C1q, and L- and M-ﬁcolins are indicated. The schematic
structures of high-order oligomers represent interpretations of
electron microscopy and atomic force microscopy studies.
Except for SP-D, which assembles in cruciform-shaped oligo-
mers of four trimers, most proteins form umbelliform-shaped
structures of six trimers for SP-A, C1q, and adiponectin, and
four trimers for MBL and ﬁcolins. The supratrimeric oligo-
merization of CL-L1, CL-K1, and CL-LK have not yet been
characterized, but it is thought that they form umbelliform-
shaped structures composed of 4–6 trimers. Nt, N-terminal
domain; COL, collagen-like domain; N, neck; Adpn, adipo-
nectin.
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six trimers forms the microﬁbril end piece in the N-terminal half below
the kink. Above the kink, approximately half-way along the collagen-
like region, individual collagen triple helices diverge at a bend to form
six individual branches, each terminating in three globular heads
(Fig. 2). It is believed that the kink functions as a hinge that permits
ﬂexible movements of the collagen stalks, modulating the position of
their adjacent globular heads (Voss et al., 1988; Reid, 2018). In the case
of MBL, the interruption of the collagenous repeat results in a kink in
only 30% of the trimers. Most of the trimers spread out from the N-
terminal hub in a ﬂexible conformation like that of ﬁcolins (Jensenius
et al., 2009). L- and M-ﬁcolin also show a 6 amino acid-interruption of
the collagen sequence but just at the beginning of the sequence, after
the ﬁrst two Gly-X-Y triplets, followed by 14 and 12 triplets, respec-
tively (Endo et al., 2007). Thus, trimers spread out from the N-terminal
hub without bending (Fig. 2).
The collagen-like regions are modiﬁed by hydroxylation of certain
proline and lysine residues in the endoplasmic reticulum before the
formation of collagen triple helix. Hydroxyproline residues have an
essential role in providing the collagen triple helices with thermal
stability and aﬀect both the arrangement of disulﬁde bonding and the
extent of oligomerization (Garcia-Verdugo et al., 2003; Jensen et al.,
2007a, b). Hydroxylation and O-glycosylation of the lysine residues
within the collagenous domain take place in SP-D (Leth-Larsen et al.,
1999), C1q (Shinkai and Yonemasu, 1979; Reid, 1979; Pﬂieger et al.,
2010), MBL (Jensen et al., 2007a, b), and adiponectin (Wang et al.,
2002). The glycosides attached to hydroxylated lysines are gluco-
sylgalactosyl groups. O-glycosylation seems to aid proper protein
folding. Importantly, three lysine residues of the collagen-like domain
of C1q, located above the kink, are completely unmodiﬁed (Pﬂieger
et al., 2010). These lysine residues (LysA59, LysB61, and LysC58) are
fully available and in an appropriate position to interact with the C1r
and C1s protease partners of C1q. Functional analysis of rC1q variants,
which carry mutations of LysA59, LysB61, and/or LysC58 in the col-
lagen-like stems, demonstrates that LysB61 and LysC58 play a key role
in the interaction with C1s-C1r-C1r-C1s (Bally et al., 2013). On the
other hand, the collagen domain of SP-D is characterized by an N-linked
glycosylation in Asn-70 with a complex type bi-antennary structure in
which no sialic acid residues are present (Leth-Larsen et al., 1999).
Trimers of collectins, ﬁcolins, C1q, or adiponectin are assembled
intracellularly into complex supratrimeric structures (Fig. 2). Electron
microscopy and atomic force microscopy techniques help us to under-
stand the supratrimeric oligomerization of soluble defense collagens.
SP-D displays a cruciform-shaped structure with a maximum of four
trimers joined N-terminally (Crouch et al., 1994). Other non-human
collectins like bovine conglutinin and CL-46 also form cruciform oli-
gomers of four trimers (Holmskov et al., 2003). SP-D may also form
oligomers of the cruciform tetramers that resemble a cart wheel or
‘fuzzy balls’ (Holmskov et al., 2003; Arroyo et al., 2018). By contrast,
SP-A, MBL, C1q, adiponectins, and ﬁcolins form supratrimeric struc-
tures that resemble the form of an umbel. These umbelliform- or ser-
tiform-shaped structures show a prominent form of six trimers for SP-A
(Voss et al., 1988; Hickling et al., 1998; Sanchez-Barbero et al., 2005,
2007), C1q (Voss et al., 1988; Bally et al., 2013), and adiponectin
(Radjainia et al., 2008). The most prominent oligomer of MBL contains
four trimers, but oligomers of 3, 5, and 6 trimers were also shown for
MBL (Jensenius et al., 2009). Oligomers of L, M, and H-ﬁcolins also
contain four trimers (Ohashi and Erickson, 1997). The majority of CL-
K1 in the circulation is in the form of the heterotrimeric collectin CL-LK,
whose size and supratrimeric oligomerization type have not yet been
characterized. It is thought that, like other collectins, CL-LK may oli-
gomerize into umbelliform-shaped structures composed of 2, 4, 5, or 6
trimers (Hansen et al., 2016).
The manner in which trimers are assembled into oligomers (um-
belliform vs. cruciform) and the length of the collagen domains of the
monomeric subunits determine the size of fully assembled defense
collagens. For instance, the size of MBL is approximately 13 nm,
whereas that of SP-D is about 100 nm (Crouch et al., 1994), which is
consistent with the SP-D function of agglutinating pathogens. Aggluti-
nation enhances mucociliary removal by the respiratory tract and
prevents attachment of pathogens to cell surfaces, avoiding microbial
colonization and invasion. Supratrimeric oligomerization of soluble
defense collagens appears to be needed for many of their functions since
oligomerization increases the functional aﬃnity of the globular domain
for their ligands and facilitates multivalent binding. For instance, mu-
tations in the collagenous region of human MBL compromise assembly
of higher order oligomers, resulting in reduced ligand binding capacity
and thus reduced capability to activate the complement. This leads to
recurrent infections and susceptibility to autoimmunity and carcino-
genesis (Larsen et al., 2004; Liu et al., 2012). Likewise, SP-A exists in
smaller oligomeric forms in allergic patients (Hickling et al., 1998), and
only the high order oligomeric form of adiponectin (6 trimers), but not
the lower oligomeric form (2 trimers), possesses anti-inﬂammatory,
anti-atherogenic and anti-diabetic functions in mice and humans (Wang
et al., 2008; Wang and Scherer, 2016).
The collagen-like domains do not function only as scaﬀolding that
ampliﬁes the ligand binding activities of globular domains. Collagenic
domains confer high tensile strength, stability and relative resistance to
proteolysis to the overall structure. Moreover, the collagen-like do-
mains are involved in binding to receptors in immune cells or to speciﬁc
serine proteases that trigger the initiation of the complement cascade
upon activation. For instance, the C1r2–C1s2 binding site in C1q is in
the middle of the C-terminal portion of the collagen-like region, close to
the kink and out from the microﬁbril-like region (Bally et al., 2013).
Similarly, MBL, ﬁcolins, CL-K1, and CL-L1 interact with their associated
proteases (MASPs) in their collagenic arms (Garred et al., 2016). In-
teractions between C1q-MASP2 and MBL-C1r/s tetramer have also been
reported in vitro. Ficolin-A-C1rs and C1q-MASP-1 complexes are also
formed (Phillips et al., 2009). However, these proteases are not asso-
ciated with the lung collectins, SP-A and SP-D, and adiponectin. The
collagen-like triple helical domains of C1q, MBL, CL-LK, and ﬁcolins are
not always masked by their associated proteases (C1r2–C1s2 or MASPs),
and thus their entire collagen-like regions are available for interaction
with receptors on cell surfaces involved in phagocytosis and clearance
of microorganisms and dead cells (apoptotic/necrotic) (Table 2). Col-
lagen-dependent functions of most soluble defense collagens have a
dual capacity to promote pathogen elimination and control inﬂamma-
tion.
With respect to the globular heads of soluble defense collagens, the
CRD of collectins belongs to the mannose/glucose-binding C-type lec-
tins that contain a highly conserved sequence [Glu-Pro-Asn] in their
CRDs, although human SP-A contains a diﬀerent sequence: Glu195-
Pro196-Ala197 (Drickamer, 1999). Collectins recognize a wide variety of
carbohydrates present in the surface of several microorganisms (mainly
mannose and N-acetyl-glucosamine) (Veldhuizen et al., 2011). How-
ever, they do not usually detect carbohydrates that decorate the
mammalian glycoproteins, such as galactose and sialic acid. Collectins
also bind a broader repertoire of ligands, including proteins, nucleic
acids, and lipids (Casals, 2001; Palaniyar et al., 2004; Wright, 2005;
Nakamura et al., 2009; Saenz et al., 2010). Despite their similar CRDs,
collectins show signiﬁcant diﬀerences in ligand preferences, which
likely extend the range of innate immune surveillance.
The FBG of L-, M-, and H- ﬁcolins bind N-acetylated glycans such as
N-acetyl-glucosamine and N-acetyl-galactosamine. Moreover, they
broadly recognize polysaccharide ligands, including peptidoglycan, li-
poteichoic acid of Gram-positive bacteria, and fungal 1,3-β-D-glucan as
well as acetylated, phosphorylated, and sulfated molecules (Bidula
et al., 2019). With respect to C1q, functional studies indicate that its
globular heads bind a wide range of self- and non-self-ligands, including
the Fc region of immunoglobulins, non-immunoglobulin targets such as
C-reactive protein, lipopolysaccharides, bacterial porins, phosphati-
dylserine (PS), and DNA. The globular head of C1q recognizes a broad
spectrum of bacterial and viral surface proteins, as well as altered self-
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elements (apoptotic cells, amyloid, and prion proteins) (Gaboriaud
et al., 2011; Thielens et al., 2017). Adiponectin, as a member of the
CTRP family, is involved in a range of biological processes such as
protection against systemic inﬂammation, clearance of dead or da-
maged cells, energy homeostasis, and tissue regeneration (Kishore
et al., 2004; Ouchi et al., 2011). Adiponectin shares some ligands with
C1q, such as DAMPs released by damaged cells, which bind to both the
collagen regions and globular heads of these proteins. Adiponectin
deﬁciency, as well as C1q and MBL deﬁciency, leads to increased sys-
temic inﬂammation, possibly due to a defect in the uptake of apoptotic
cells (Takemura et al., 2007; Monticielo et al., 2008; Stegert et al.,
2015).
3. Role of soluble defense collagens in the resolution of
inﬂammation
In addition to eﬃciently clearing infection (Fig. 1), soluble defense
collagens share the ability to resolve the inﬂammation by limiting
macrophage pro-inﬂammatory activation and promoting clearance of
apoptotic cells (Fig. 3).
3.1. Downregulation of inﬂammation
With respect to macrophages and monocytes, soluble defense
collagens inﬂuence cell responses to limit inﬂammation by several
mechanisms. First, they block the interaction of TLR ligands with their
receptors. This eﬀect can be exerted by i) direct binding to TLR2, TLR3,
TLR4, the TLR co-receptor MD2, and CD14, as demonstrated for SP-A,
SP-D, and MBL (Garcia-Verdugo et al., 2005; Wang et al., 2011, 2013;
Liu et al., 2014; Casals et al., 2018; Wang et al., 2019); or ii) direct
interaction with TLR ligands, as shown for SP-A, SP-D, and H-ﬁcolin,
which bind to the TLR4 ligand LPS (Michalski et al., 2015; Casals et al.,
2018); and for MBL, which binds to the TLR3 ligand poly(I:C) (Liu
et al., 2014). Second, they modify macrophage response to TLR ligands
by modulating signaling cascades. For example, SP-A and adiponectin
enhance the expression of negative regulators of TLR-signaling, such as
IRAK-M (Nguyen et al., 2012; Zacharioudaki et al., 2009), and inhibit
activation of NFκB, ERK, and other signaling molecules (Henning et al.,
2008; Mandal et al., 2010; Casals et al., 2018). C1q also inhibits the
activation of NFκB heterodimers p50/p65 through activation of in-
hibitory homodimers p50/p50 and CREB (Fraser et al., 2007). Third,
they promote the activation of the SHP-1-dependent signaling pathway
that blocks proinﬂammatory mediator production. Inhibitory SHP-1
phosphatase is activated by binding of SP-A and SP-D to the SIRP-α
receptor through their globular heads (Gardai et al., 2003), as well as
by binding of C1q to the inhibitory receptor LAIR-1 through C1q col-
lagen tails (Son and Diamond, 2015; Son et al., 2016). Fourth, through
binding to IFN-γ, SP-A suppresses IFN-γ interaction with its IFN-γR1
Table 2
Common receptors for two or more soluble defense collagens.
Receptor Protein name (domain) Biological function References
cC1qR, receptor for the collagen tail of
C1q (aka calreticulin)
• C1q (collagen and
globular heads)
• MBL (collagen, MASPs
binding site)
• SP-A (collagen)• SP-D• CL-K1• Ficolins (collagen,
MASPs binding site)
• Adiponectin
• Eﬀerocytosis Dong et al. (2017),
Lacroix et al. (2009), Ogden et al. (2001),
Pagh et al. (2008), Paidassi et al. (2011),
Takemura et al. (2007),
Vandivier et al. (2002)
gC1qR, receptor for the globular head of
C1q (aka p33)
• C1q (globular heads)• MBL •
Attachment and phagocytosis of pathogens Brudner et al. (2013),
Peerschke and Ghebrehiwet (2007)
LRP1 (CD91) aka α-2-macroglobulin
receptor
• C1q (collagen and
globular heads)
• MBL (collagen, MASP
binding site)
• L-ﬁcolin
• Phagocytosis of microbial and apoptotic material Duus et al. (2010a,b)
CR1 (CD35) • C1q (collagen and
globular heads)
• MBL (collagen, MASPs
binding site)
• Ficolins (collagen,
MASPs binding site)
• Possible role in the phagocytosis of opsonized particles
or immune complexes
Jacquet et al. (2013, 2018)
α2β1 and β1 integrin • C1q• MBL• SP-A
• Activation of mast cells Edelson et al. (2006)
LAIR-1 (CD305) aka inhibitory Ig-like
leukocyte-associated receptor
• C1q (collagen)• MBL• SP-D (collagen)
• Restriction of dendritic cells’ diﬀerentiation and
activation
• Anti-inﬂammatory action on neutrophils• Polarization of monocytes to an anti-inﬂammatory
phenotype (in complex with RAGE and HMGB1)
Olde Nordkamp et al. (2014a, 2014b),
Son and Diamond (2015),
Son et al. (2016)
Myo18A (CD245) aka SPR2101 • SP-A (collagen)• C1q •
Enhance alternative activation of macrophages and
promote tissue repair
• Promote phagocytosis of microorganisms
Sever-Chroneos et al. (2011),
Minutti et al. (2017a)
SIRP-α (CD172a) • SP-A (globular heads)• SP-D (globular heads)• CL-K1
• Blocks production of pro-inﬂammatory mediators in
macrophages (SP-A and SP-D) and retinal pigment
epithelial cells (CL-K1)
Gardai et al. (2003), Fournier et al.
(2012),
Dong et al. (2017)
TLR4
CD14
MD-2
TLR2
• SP-A (globular heads)• SP-D (globular heads)• MBL
• Inhibit binding of TLR ligands to immune cells and
downregulate pro-inﬂammatory activation
Garcia-Verdugo et al. (2005),
Sano et al. (1999), Sorensen (2018),
Wang et al. (2011, 2013, 2019), Yamada
et al. (2006)
CR3 (CD11b/CD18) aka Mac-1, αMβ2
integrin
• C1q (collagen)• SP-A (N-linked sugars,
CRD, and neck)
• Complement receptor-mediated phagocytosis and
eﬀerocytosis
Gil et al. (2009),
Ma et al. (2012)
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receptor and inhibits activation of human and murine alveolar macro-
phages (Minutti et al., 2016). In addition, C1q and adiponectin inhibit
LPS-induced inﬂammasome activation (Benoit et al., 2012; Kim et al.,
2017), and SP-D, SP-A, and adiponectin reduce the production of re-
active oxygen species (ROS) (Yoshida et al., 2001; Crowther et al.,
2004; Kim et al., 2014).
Besides limiting inﬂammation, soluble defense collagens contribute
to enhance alternative activation of macrophages toward an anti-in-
ﬂammatory and resolving phenotype (Fig. 3). Adiponectin promotes
alternative macrophage activation (Ohashi et al., 2010) and secretion of
anti-inﬂammatory cytokines (Park et al., 2008). The anti-inﬂammatory
eﬀect of adiponectin seems to be exerted through the expression of IL-4
by macrophages and subsequent activation of STAT6 upon binding of
adiponectin to its receptor AdipoR2 (Mandal et al., 2011). C1q and MBL
also promote macrophage activation to a resolving phenotype since
both C1q and MBL enhance the expression of anti-inﬂammatory cyto-
kines such as IL-10 or IL-1R antagonist (Fraser et al., 2006, 2009),
which may be due in part to C1q-mediated activation of the inhibitory
transcription factor CREB (Fraser et al., 2007). C1q also promoted al-
ternative macrophage activation during clearance of oxLDL (Spivia
et al., 2014). It is believed that the anti-inﬂammatory role of C1q
parallels its capability to enhance the clearance of apoptotic cells by
macrophages (Benoit et al., 2012; Hulsebus et al., 2016; Thielens et al.,
2017), which leads to the production of IL-10 and TGFβ (Greenlee-
Wacker, 2016). Finally, we have recently shown that SP-A and C1q
enhance IL-4-induced alternative activation and proliferation of mac-
rophages through binding to myosin 18A (Minutti et al., 2017a). The
possible anti-inﬂammatory eﬀect of CL-L1 and CL-K1 on monocytes or
macrophages has not yet been studied, and further studies are needed
to determine their contribution in the resolution of inﬂammation.
Defense collagens also modulate the activation of immune cells
other than monocytes and macrophages. With respect to dendritic cells,
it has been reported that C1q has an essential role in these cells’ uptake
of antigens to elicit antigen presentation (Ho et al., 2017). The inhibi-
tion of dendritic cell maturation and activation was demonstrated for
C1q (Santer et al., 2010; Teh et al., 2011; Santer et al., 2012), MBL
(Dean et al., 2011; Xu et al., 2015), adiponectin (Tsang et al., 2011; Tan
et al., 2014), SP-A (Brinker et al., 2003), and SP-D (Liu et al., 2010).
Downregulation of dendritic cell maturation and activation contributes
to the protective eﬀect of C1q (Mascarell et al., 2017), SP-A, and SP-D
(Wang and Reid, 2007; Liu et al., 2010) in mouse models of allergic
asthma. With respect to eosinophils, adiponectin, SP-D, and SP-A in-
hibit eosinophil recruitment and/or degranulation, limiting inﬂamma-
tion in allergic mouse models (von Bredow et al., 2006; Medoﬀ et al.,
2009; Ledford et al., 2012). Regarding neutrophils, SP-D inhibits ROS in
a neutrophilic cell line by binding to the inhibitory receptor LAIR-1 via
SP-D collagen tails (Olde Nordkamp et al., 2014b), and adiponectin also
reduces activation of neutrophils and ROS production, which is asso-
ciated with increased AMPK phosphorylation and decreased p47(phox)
phosphorylation in phagocytes (Chedid et al., 2012). In contrast, C1q
and MBL seem to enhance ROS production by neutrophils (Goodman
et al., 1995; Li et al., 2012). With respect to lymphocyte diﬀerentiation,
it has been shown that C1q indirectly promotes diﬀerentiation of the
regulatory T cell subset and inhibits the Th1 and Th17 subsets via po-
larizing antigen presenting cells (reviewed in Thielens et al., 2017). SP-
A and SP-D also inhibit T cell proliferation and activation (Kunzmann
et al., 2006; Mukherjee et al., 2012a; Sorensen, 2018), and SP-A induces
the diﬀerentiation of Treg cells via TGFβ (Mukherjee et al., 2012b).
Moreover, MBL and CL-K1, as well as C1q, have recently been shown to
suppress T cell proliferation through binding to calreticulin expressed
on the surface of T lymphocytes (Zhao et al., 2017).
3.2. Clearance of apoptotic cells
Soluble defense collagens are also eﬃcient sensors of altered self-
signals, so-called DAMPs. Dying cells are a rich source of DAMPs, as
they expose a large variety of otherwise intracellular molecules on the
cell surface when the membrane of the dying cell loses integrity
(Matzinger, 1994). By recognizing DAMPs exposed by dying cells, so-
luble defense collagens take part in the process of clearing apoptotic
cells. The phagocytic clearance of dying cells (eﬀerocytosis) by mac-
rophages and other phagocytes is essential during embryonic develop-
ment and to maintain tissue homeostasis and self-tolerance (Poon et al.,
2014).
With respect to DAMPs, SP-A, SP-D, MBL, CL-K1, C1q, and L-Ficolin
recognize DNA by their globular heads (Jiang et al., 1992; Tissot et al.,
Fig. 3. Soluble defense collagens promote resolution of
inﬂammation. This group of proteins shares the ability to
downregulate inﬂammation and facilitate the clearance of
dying cells. For clarity in drawing, two members of this family
— SP-A (dark red) and C1q (light green) — are drawn to show
the molecular mechanisms by which these proteins inﬂuence
macrophage responses to limit inﬂammation. For example,
they bind to TLRs, blocking the binding of TLR ligands, and
promote the activation of SHP-1-dependent signaling
pathway, which blocks proinﬂammatory mediator production.
They enhance the expression of anti-inﬂammatory cytokines,
and receptors involved in eﬀerocytosis (Mertk, SR-A1, or
CR3). In addition, they recognize DAMPs exposed by dying
cells such as calreticulin (CRT), acting as a bridging molecule
by binding to macrophage receptors involved in cell uptake
(such as LRP1). Adiponectin (Adpn)/AdipoR2 interaction is
also shown. Some soluble defense collagens also stimulate IL-
4Rα-mediated macrophage activation toward an anti-in-
ﬂammatory resolving phenotype involved in tissue repair.
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2003; Palaniyar et al., 2003, 2004; Jensen et al., 2007a, b; Paidassi
et al., 2008a; Garlatti et al., 2010a; Henriksen et al., 2013); most of
them recognize calreticulin (see Table 2); and SP-A, MBL and C1q bind
to PS, the canonical marker of apoptotic cells (Kuroki et al., 1997;
Kilpatrick, 1998; Paidassi et al., 2008b; Jakel et al., 2010; Tan et al.,
2010). Soluble defense collagens bind to apoptotic cells and serve as
bridging molecules, linking the apoptotic cell to the phagocyte. This
requires the interaction of these proteins with membrane receptors on
the phagocyte membrane.
A common receptor for C1q, MBL, and SP-A was characterized by
Malhotra et al. (1990a, b) and subsequently identiﬁed as calreticulin
(Sim et al., 1998). Paradoxically, calreticulin does not have a trans-
membrane domain nor a membrane anchor. Calreticulin is normally
localized in the lumen of the endoplasmic reticulum, but it is also de-
tected on the cell surface of phagocytes and viable or apoptotic cells
(Gardai et al., 2005; Feng et al., 2018). It was demonstrated that acti-
vated macrophages secrete calreticulin, which binds to the surface of
viable or dying cells and marks them for removal by phagocytosis (Feng
et al., 2018). However, viable cells seem to be protected from engulf-
ment by repelling signals expressed on the cell surface, such as CD31,
CD200, and CD47 (Gardai et al., 2005; Chao et al., 2011). It has been
proposed that calreticulin acts as a recognition ligand by binding and
activating LDL-receptor-related protein 1 (LRP1 aka CD91) on the en-
gulﬁng cell (Gardai et al., 2005). However, no direct interaction be-
tween isolated LRP1 and calreticulin has yet been demonstrated
(Donnelly et al., 2006; Duus et al., 2010a; Frachet et al., 2015). By
contrast, the collagenous arms of soluble defense collagens bind directly
to CD91 and calreticulin (see Table 2), mediating phagocytic uptake of
apoptotic cells. This suggests that LRP1 may serve as a docking platform
for recognition of calreticulin exposed on the surface of dying cells,
which depends on soluble defense collagens (Fig. 3). Nevertheless, cell
surface-anchored calreticulin interacts not only with bridging mole-
cules (C1q, adiponectin, MBL, SP-A, SP-D, CL-K1, ﬁcolins) but also with
other molecules involved in eﬀerocytosis such as PS on apoptotic cells
and scavenger receptors on phagocytes (Frachet et al., 2015), sug-
gesting that calreticulin-mediated eﬀerocytosis could be regulated by
complex multimolecular interactions.
Another receptor that may be involved in clearance of dead cells is
myosin 18A (CD245), also known as SPR-210 (surfactant protein re-
ceptor 210 kDa) (Chroneos et al., 1996). This protein was ﬁrst puriﬁed
from the macrophage cell line U937 and later identiﬁed as myosin 18A
(Yang et al., 2005). It is normally located inside the cells as part of the
cytoskeleton (Tan et al., 2008; Dippold et al., 2009; Ng et al., 2013) and
on the cell surface of diﬀerent tissue macrophages when stimulated
with IL-4, and on other leucocyte populations (Minutti et al., 2017a; De
Masson et al., 2016). The interaction between SP-A and myosin 18A
takes place through the collagen tail of SP-A (Borron et al., 1998;
Minutti et al., 2017a). C1q also binds to myosin 18A (Minutti et al.,
2017a), probably by its collagen domains, although direct binding
studies are lacking. Experiments using blocking antibodies against
myosin 18A revealed that the SP-A/myosin 18A axis is involved in the
uptake of bacteria, and probably dead cells, by macrophages (Sever-
Chroneos et al., 2011). Myosin 18A does not have a transmembrane
domain; it might therefore function as an adaptor molecule during the
recognition of altered-self material by SP-A or C1q. Although the
transmembrane receptor that recognizes SP-A/C1q associated with
myosin 18A has yet to be discovered, the group of Zissis Chroneos
identiﬁed a functional association of myosin 18A with the phagocytic
SR-A1 (Sever-Chroneos et al., 2011; Yang et al., 2015). Furthermore, it
has been shown that myosin 18A co-localizes with integrin β1 (Byron
et al., 2012), which is another receptor for some soluble defense col-
lagens (C1q, MBL, and SP-A) (Zutter and Edelson, 2007). Interestingly,
integrin α2β1 interacts with calreticulin at the surface of various cells
(Elton et al., 2002).
With respect to receptors for complement components that coat the
surface of apoptotic cells and facilitate ingestion by macrophages, CR1
(CD35) and CR3 (aka Mac-1, integrin αMβ2) are phagocytic receptors
involved in the recognition of C3b and iCb3 fragments and several
soluble defense collagens (see Table 2). Complement may be activated
in a controlled manner on the surface of damaged or apoptotic cells to
proceed until C3b surface deposition (Zipfel and Skerka, 2009). Opso-
nized apoptotic cells can be removed by binding to CR1 and CR3 on
phagocytes. As indicated above, these receptors are also involved in the
recognition of soluble defense collagens (Table 2). It was recently de-
monstrated the predominant role of C1q, rather than C1 activation and
C3b deposition, on clearance of early apoptotic cells, since C1s inhibi-
tion did not impact C1q binding to dying cells and uptake of dying cells
(Colonna et al., 2016). Direct binding of CR3 to C1q (Ma et al., 2012)
and SP-A (Gil et al., 2009) has been demonstrated. The collagenous tail
of SP-A augments CR3-mediated phagocytosis (Gil et al., 2009). On the
other hand, CR1 interacts with MBL (Ghiran et al., 2000) and L-ﬁcolin
(Jacquet et al., 2013) near the MASP binding site in their collagenous
tails. At the same time, MBL, SP-A, and ﬁcolins can bind to dying cells
by their globular heads. CR1 interacts with both collagen stalks and
globular heads of C1q (Klickstein et al., 1997; Jacquet et al., 2018).
Another mechanism by which soluble defense collagens promote
eﬀerocytosis is by enhancing the expression of PS receptors on mac-
rophages: AXL receptor tyrosine kinase (Axl) and c-mer proto-oncogene
tyrosine kinase (Mertk). C1q and adiponectin enhance the expression of
Mertk by activating AMPK phosphorylation and the nuclear retinoid X
receptor on macrophages (Galvan et al., 2012, 2014). Consequently,
C1q and adiponectin promote Mertk-dependent clearance of apoptotic
cells. In addition, SP-A and MBL increase the expression of SR-A1 (Ono
et al., 2006; Kuronuma et al., 2004), which interacts with Mertk and is
thought to promote Mertk signaling during apoptotic cell uptake (Todt
et al., 2008) (Fig. 3). SP-A also enhances the expression of other pha-
gocytic receptors such as CD36 (Dodd et al., 2016), mannose receptor
(Beharka et al., 2002, 2005), and CR3 (Gil et al., 2009).
Alterations in the normal clearance of apoptotic cells and immune
complexes cause high levels of DAMPs and autoantigens that are pre-
sented inappropriately to the immune system, promoting inﬂammation
and autoimmune diseases (Grumach and Kirschﬁnk, 2014). Deﬁciencies
of C1q and MBL are associated with the development of the auto-
immune pathology systemic lupus erythematosus (SLE) (Monticielo
et al., 2008; Stegert et al., 2015). Complete genetic deﬁciency of C1q is
strongly associated with SLE, and subtle variations in the abundance
and activity of the protein (i.e. partial deﬁciency, point mutations, or
auto antibodies against C1q) predispose to the development of SLE
symptoms (Frachet et al., 2015). Low levels of MBL, due to MBL-2 gene
polymorphisms or anti-MBL autoantibodies, are associated with sus-
ceptibility to autoimmune diseases and SLE (Monticielo et al., 2008).
Interestingly, low levels of CL-L1, CL-K1, and M-ﬁcolin have also been
found to be associated with SLE (Troldborg et al., 2018). Auto-anti-
bodies against L- and H-ﬁcolin have been found in SLE patients, cor-
relating with disease activity (Colliard et al., 2018; Plawecki et al.,
2016), and H-ﬁcolin deﬁciency is linked to diﬀerent diseases, including
SLE (Troldborg et al., 2019). Similarly, it has been shown that adipo-
nectin deﬁciency leads to high accumulation of apoptotic cells, systemic
inﬂammation, and autoimmune phenotype in lpr mice, which are al-
ready susceptible to autoimmunity since they exhibit impaired uptake
of dead cells (Takemura et al., 2007). In contrast, high levels of serum
adiponectin and H-ﬁcolin are often found in SLE patients (Dini et al.,
2017; Hein et al., 2015; Li et al., 2016). Therefore, the causes and
consequences of altered levels of CL-L1, CL-K1, adiponectin, and ﬁco-
lins in SLE have yet to be determined.
4. Role of soluble defense collagens in tissue repair
After inﬂammation declines, macrophages actively sustain tissue
formation and remodeling so that the injured tissue returns to nor-
mality. Tissue repair activities of macrophages at these stages are as-
sociated with type II cytokine activation through the IL-4Rα receptor.
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Global and cell-speciﬁc myeloid cell disruption of the IL-4Rα gene was
shown to cause tissue repair deﬁciencies in the skin (Knipper et al.,
2015), lung, and liver (Minutti et al., 2017a; Chen et al., 2012) in
diﬀerent models of injury. Mechanistically, it has been proposed that IL-
4Rα-activation of macrophages induces the secretion of growth factors
like IGF-1 (Han et al., 2016) and the production of repair factors such as
collagen type I, alpha 1 (Col1a1), which forms the extracellular matrix;
resistin-like molecule alpha (RELMα), which serves to cross-link col-
lagen with ﬁbrils; and arginine-derived polyamines, which are neces-
sary for collagen synthesis and cell proliferation (Mantovani et al.,
2013; Knipper et al., 2015; Minutti et al., 2017b; Krljanac et al., 2019).
Furthermore, IL-4Rα signaling instructs macrophage proliferation, re-
sulting in the local expansion of this eﬀector population (Jenkins et al.,
2011).
Our group has recently reported that IL-4 and IL-13 may not be
suﬃcient for the activation of tissue macrophages and that involvement
of local tissue signals is also required (Minutti et al., 2017a). SP-A, in
the lung, and C1q, in the liver, enhance IL-4Rα-dependent alternative
activation, proliferation, and tissue-repair functions of resident mac-
rophages through binding their collagen domains to the myosin 18A
receptor (Minutti et al., 2017a) (Fig. 4). IL-4 drives production of these
tissue factors (SP-A and C1q) and expression of their myosin 18A re-
ceptor on the macrophage surface for full IL-4-dependent activation and
proliferation. Loss of function studies using SP-A- and C1qa-deﬁcient
mice demonstrated that SP-A and C1q are necessary to promote tissue
repair during lung and liver infection with the parasite N. brasiliensis
and the Gram positive bacterium Listeria monocytogenes, respectively
(Minutti et al., 2017a). SP-A and C1q are tissue speciﬁc since SP-A, but
not C1q, enhances IL-4-dependent eﬀects on alveolar macrophages, and
C1q has eﬀects on peritoneal and liver macrophages. These tissue-
speciﬁc functions are likely determined by distinct as yet unknown
myosin 18A co-receptors.
To guarantee eﬃcient repair, macrophages must also diminish their
inﬂammatory response, which otherwise impairs the process (Vannella
and Wynn, 2017). As indicated above, defense collagens downregulate
inﬂammation and eﬃciently encourage the clearance of apoptotic cells
(Fig. 3). Importantly, it was recently shown that IL-4Rα-dependent
tissue repair requires concomitant recognition and clearance of apop-
totic cells by macrophages (Bosurgi et al., 2017). The authors identiﬁed
the PS receptors, Axl and Mertk, to be essential for promoting IL-4Rα-
induced tissue repair. Deletion of PS receptor genes Mertk and Axl
impairs IL-4-dependent induction of macrophage proliferation and
tissue repair genes in the lung, after N. brasiliensis infection, and the gut,
in a model of colitis. Control studies indicate that Axl−/−Mertk−/−
doubly deﬁcient macrophages show normal induction of genes for
pattern recognition receptor, cell adhesion, and chemotaxis in response
to IL-4 (Bosurgi et al., 2017). This study provided the ﬁrst example of
how our body restricts macrophage tissue repair activities to the da-
maged site.
The activation of tissue repair in macrophages requires integration
of several external signals from the tissue environment: i) IL-4/IL-13
cytokines; ii) soluble defense collagens; and iii) dying cells and their
subsequent uptake (Fig. 4). Intriguingly, there is a link between IL-4
and tissue factors (SP-A or C1q), since IL-4 increases SP-A, C1q, and
myosin 18A levels. There is also a connection between tissue factors
and eﬀerocytosis, since C1q increases the expression of Mertk, and SP-A
increases the expression of SR-A1, which promotes Mertk signaling
(Kuronuma et al., 2004; Ono et al., 2006; Todt et al., 2008; Galvan
et al., 2012, 2014). In addition, SP-A and C1q act as bridging molecules
in the eﬀerocytic process. These data suggest that the activation of a
tissue repair program in macrophages could be regulated by a complex
process of integrated multimolecular signaling (Fig. 4).
With respect to adiponectin, IL-4 also increases the secretion of
adiponectin by adipocytes (Lizcano et al., 2017), and adiponectin en-
hances secretion of IL-4 by peritoneal macrophages through binding to
its receptor (adipoR2) (Mandal et al., 2011), resulting in the induction
of arginase and other markers of alternative activation (Ohashi et al.,
2010). Moreover, adiponectin promotes proliferation of IL-4-activated
macrophages through activation of PI3K upon binding to the GPI-an-
chored protein T-cadherin (Hui et al., 2015). Intriguingly, adiponectin
exerts anti-ﬁbrogenic functions on hepatic stellate cells, the major ﬁ-
brogenic cell type in the liver (Higashi et al., 2017). Adiponectin at-
tenuates liver ﬁbrosis by inducing nitric oxide production (via the
adipoR2/AMPK/NF-κB pathway) and inhibits hepatic stellate cell pro-
liferation. In addition, adiponectin increases TIMP-1 secretion, which
binds to the CD63/1-integrin complex to decrease FAK activity and
stellate cell migration (reviewed in Higashi et al., 2017). These adipo-
nectin antiﬁbrotic actions support its role in tissue repair.
The contribution of other soluble defense collagens in tissue repair
is scarcely known. Using SP-D-deﬁcient mice, Horsnell’s group showed
that N. brasiliensis infection of SP-D-deﬁcient mice results in profound
impairment of host innate immunity and ability to resolve infection,
another function attributed to IL-4Rα-activated macrophages. The au-
thors showed that SP-D also enhanced IL-4Rα-mediated macrophage
activation in the lung (Thawer et al., 2016), and IL-4 increases the
expression of SP-D in the lung (Ikegami et al., 2000; Haczku et al.,
Fig. 4. The activation of tissue repair in macrophages re-
quires integration of several external signals from the
tissue environment: 1) Type 2 cytokines, through IL-4Rα,
induce the expression of key tissue repair factors in macro-
phages (Arg1, Retnla, Col1a1, and Igf1). IL-4 also enhances the
production of tissue-speciﬁc factors (C1q in the liver and SP-A
in the lung) and the expression of myosin18A on the cell
surface of macrophages. 2) C1q and SP-A enhance the pro-
duction of tissue repair factors induced by IL-4. 3) The re-
cognition and uptake of apoptotic cells through Mertk and Axl
receptors amplify the gene signature induced in macrophages
by IL-4/13. C1q increases the expression of Mertk, and SP-A
increases the expression of SR-A1, which boosts Mertk sig-
naling, promoting eﬀerocytosis. Arg1, arginase 1; Retnla, re-
sistin-like molecule alpha; Col1a1, collagen type I, alpha 1;
Igf1, insulin-like growth factor 1.
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2006). Despite the fact that ﬁcolins belong to the ﬁbrinogen-related
proteins, which are a group of extracellular molecules with important
roles in tissue repair for many of its members (Zuliani-Alvarez and
Midwood, 2015), there are no data yet on the implication of ﬁcolins in
this process.
Macrophages clear dying cells and promote tissue regeneration, but
overactivated macrophages responding to tissue damage may cause
exaggerated repair responses and ﬁbrotic lesions (Gieseck et al., 2018).
In this vein, we found that C1q signiﬁcantly ampliﬁes peritoneal ﬁ-
brosis induced by a lactate dialysate; it does so by promoting an anti-
inﬂammatory peritoneal macrophage phenotype driven by lactate and
dependent on HIF1α (Minutti et al., 2017a). C1q had been previously
shown to promote ﬁbrosis in aging skeletal muscle through activating
Wnt signalling, resulting in impairment of muscle regeneration due to
decreased proliferation of myocyte precursors parallel to increased
proliferation of ﬁbroblasts and increased collagen release from ﬁbro-
blasts (Naito et al., 2012). This indicates that C1q can exacerbate ﬁ-
brosis in cells other than macrophages. Another example of the parti-
cipation of C1q in tissue remodeling and repair may be inferred from its
recently discovered role in the central nervous system. As reviewed by
Tenner and colleagues (2018), C1q is a key mediator of synapse elim-
ination by “tagging” weak or immature synapses for elimination by
adjacent microglia (a process called synapse pruning) in the healthy
developing brain. However, aberrant synapse pruning could mediate
pathological synapse loss in neurodevelopmental and neurodegenera-
tive disorders, such as Alzheimer’s disease (Tenner et al., 2018). Further
studies should be done to explore the implication of soluble defense
collagens in protection from or aggravation of chronic diseases that are
associated with dysregulated tissue repair and remodeling.
5. Concluding remarks
Three decades ago, it was thought that proteins containing collagen
domains were present only in the extracellular matrix and have only a
structural role. However, it was recognized at the end of the 1980s that
the type 1 scavenger receptor, whose trimeric structure includes a ﬁ-
brous extracellular collagenous domain, participates in host defense
activities by recognizing and mediating the endocytosis of pathogens
(Krieger et al., 1993). The collagen domain of the scavenger receptor
was considered as molecular ﬂypaper for high aﬃnity binding of spe-
ciﬁc polyanions. In the same period, it was proved that several proteins
secreted to serum and tissue cavities (such as C1q, MBL, SP-A, and
conglutinin) contained short collagen domains and were also involved
in host-defense (Reid, 1979; Drickamer et al., 1986; Haagsman et al.,
1987; Voss et al., 1988; Thiel and Reid, 1989). All these proteins have a
selectively sticky surface and were involved in clearing the extracellular
space of debris, including pathogenic material. This growing family of
proteins is of great clinical interest for various diseases.
Apart from their collagen domains, one common physical property
of these proteins is their high-order oligomerization in umbelliform- or
cruciform-shaped structures composed of trimeric units. Such oligo-
merization is integral to these proteins’ biological functions and must be
under substantial selection pressure. It is evident that these proteins
have evolved to use protein oligomerization as a tool for the control and
execution of many of their distinct functions. Oligomerization confers
structural and functional advantages. It improves stability and control
over the accessibility and functional aﬃnity of their binding regions
(globular and collagen-like domains). Moreover, it facilitates multi-
valent binding to their ligands. However, unwanted oligomerization of
proteins can also lead to the formation of pathogenic structures, sug-
gesting that structure-function studies of these proteins in pathological
states should be intensively explored. In addition, the expression of the
functionally active recombinant form of these proteins and the gen-
eration of point mutation variants would aid understanding, at the
molecular level, of the functions of these complex and versatile pro-
teins.
C1q, MBL, and adiponectin deﬁciency lead to increased systemic
inﬂammation, possibly due to a defect in the uptake of apoptotic cells
(Takemura et al., 2007; Monticielo et al., 2008; Stegert et al., 2015).
Inherited deﬁciency of H-ﬁcolin results in chronic disabling infections
(Munthe-Fog et al., 2009; Schlapbach et al., 2011). Decreased SP-A/-D
levels are commonly observed in lung diseases (Ledford et al., 2014;
Sorensen, 2018). However, SP-A/-D decrease may be a consequence of
the diseased lung environment as proteins are partially degraded, oxi-
dized, and present in smaller oligomeric forms. Much of what we know
about the protective role of SP-A and SP-D, and other defense collagens,
has arisen from studies using gene-deﬁcient mice in murine models of
several diseases.
Besides protecting from invading pathogens, soluble defense col-
lagens are involved in controlling inﬂammation. They modulate mac-
rophages toward an anti-inﬂammatory resolving phenotype and reduce
the activation of immune cells other than macrophages. Soluble defense
collagens detect and promote the uptake of dying cells caused by tissue
damage and are key factors for macrophage-driven repair programs
that restore homeostasis. Identiﬁcation of the key receptors involved in
these processes will aid to elucidate the tissue-speciﬁc role of these
proteins. Moreover, this will allow the generation of cell-targeted gene-
deﬁcient mice to complete more sophisticated studies. Eﬀorts in un-
derstanding the molecular and cellular mechanisms that govern mac-
rophage-driven repair programs in health and disease will aid in the
development of macrophage-directed therapeutic targets.
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